Inequalities in initiation of COVID19 vaccination by age and population group in Israel- December 2020-July 2021

This article has been Reviewed by the following groups

Read the full article See related articles

Abstract

No abstract available

Article activity feed

  1. SciScore for 10.1101/2021.06.14.21258882: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    NIH rigor criteria are not applicable to paper type.

    Table 2: Resources

    No key resources detected.


    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).


    Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:
    Strengths, limitations and further directions: This study is to our knowledge the first to describe how age and belonging to a particular group interact to influence COVID19 vaccine coverage in Israel. Our study has used comprehensive datasets taken from official governmental databases, covering the majority of the population is Israel. Bias and representativeness are therefore unlikely to be issues. We excluded municipalities in which the population was too diverse to assign it to a particular category. This concerns a large proportion of the population, including Jerusalem, Israel’s largest city. There are several limitations to this study. First, the most recent demographic data was from 2018, which leads to a slight underestimation of the denominator and over estimation of vaccine coverage. However the timeframe between 2017 and 2021 is too short to significantly impact on the relative distribution of the population by age or population group, and relative measures are therefore unlikely to be significantly affected. We applied a correction factor based on national growth to try and minimize the effect of an underestimated denominator. However a few cities have undergone extensive growth since 2017. This made the denominator (i.e., population in 2017) smaller than the numerator (i.e., number of people vaccinated) in those cities. Data for these municipalities was uninterpretable and therefore excluded. We also made the assumption that the population groups considered in t...

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.


    Results from JetFighter: We did not find any issues relating to colormaps.


    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    Results from scite Reference Check: We found no unreliable references.


    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.